Base · 30 · Uncommon · 1999
The raw price over time, with any graded series laid over the same axis — the comparison a grading decision turns on.
Premium23 graded series can be laid over this line — see what the slab did while the raw price moved.Unlock
Every graded price published, next to how many copies exist at that grade.
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶PSA 10 | $125 $98.99–$300 from sold comps | 20.4× | 867 | 0 |
| ▶PSA 9 | $45.50 $33.00–$64.99 from sold comps | 7.4× | 1,969 | 867 |
| ▶PSA 8.5 | $45.79 | 7.5× | 9 | 2,836 |
| ▶PSA 8 | $47.25 $43.99–$50.00 | 7.7× | 1,273 | 2,845 |
| ▶PSA 7 | $42.16 | 6.9× | 605 | 4,120 |
| ▶PSA 6 | $31.52 | 5.1× | 349 | 4,726 |
| ▶PSA 5 | $24.91 | 4.1× | 238 | 5,075 |
| ▶PSA 4 | $27.53 | 4.5× | 109 | 5,313 |
| ▶PSA 3 | $26.68 | 4.4× | 47 | 5,423 |
| ▶PSA 2 | $19.99 unverified | 3.3× | 28 | 5,470 |
| ▶PSA 1 | $64.99 unverified | 10.6× | 18 | 5,499 |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶BGS 9 | $50.19 | 8.2× | — | — |
| ▶BGS 8.5 | $42.20 | 6.9× | — | — |
| ▶BGS 8 | $28.96 | 4.7× | — | — |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶CGC 10 | $91.17 | 14.9× | — | — |
| ▶CGC 9.5 | $33.39 | 5.4× | — | — |
| ▶CGC 9 | $39.98 | 6.5× | — | — |
| ▶CGC 8.5 | $22.90 | 3.7× | — | — |
| ▶CGC 8 | $16.89 | 2.8× | — | — |
| ▶CGC 7.5 | $24.74 | 4.0× | — | — |
| ▶CGC 7 | $21.50 | 3.5× | — | — |
| ▶CGC 6.5 | $16.00 | 2.6× | — | — |
| ▶CGC 6 | $16.75 | 2.7× | — | — |
| ▶CGC 5.5 | $22.50 | 3.7× | — | — |
| ▶CGC 5 | $10.00 | 1.6× | — | — |
A model's opinion, not investment advice.